Brian Perez, MD
Adult Reconstructive Orthopaedic Surgery · Cedar Knolls, NJNPI 1598254443
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (47.0%), grants and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 89.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2023 at $25,070 and has fallen 92.5% since, to $1,887 in 2025.
Across 51 payments — averaging $1044.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$48K
- Stryker$2K
- Zimmer Biomet$2K
- Paladin Technology Solutions$1K
- Kerecis Limited$242
- Davol Inc.$191
- plus $207 from 2 others
What the payments were for
- Grants$23,75045%
- Travel & lodging$9022%
- Food & beverage$3,5877%
- Education$25,02747%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 4 | $47,758 |
| Stryker | 25 | $2,123 |
| Zimmer Biomet | 14 | $1,545 |
| Paladin Technology Solutions | 1 | $1,200 |
| Kerecis Limited | 3 | $242 |
| Davol Inc. | 2 | $191 |
| Intellijoint Surgical Inc. | 1 | $139 |
| Seapearl East, Inc | 1 | $68 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$1,049
- Oxford$590
- Kerecis SurgiClose$543
- ROSA$150
- EVOS$146
- T2$144
- Channel Drain$142
- Intellijoint HIP$139
- Kerecis GraftGuide$136
- VARIAX$133
- Persona$129
- REAL INTELLIGENCE$112
- Journey II$112
- TIMBERLINE MPF LATERAL MODULAR PLATE FIXATION SYSTEM$111
How this compares
$53,266 in reported general payments places this provider in the 70th percentile of 39 adult reconstructive orthopaedic surgery providers in New Jersey.
See all adult reconstructive orthopaedic surgery providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 84 | $220 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Cedar Knolls
- Atul KamathManasquan$4M
- Alfred TriaSomerset$582K
- John DundonHackettstown$573K
- Ismar DizdarevicRidgewood$368K
- David FeldmanEnglewood$335K
- Mark PizzurroRidgewood$239K
- Jeffrey LearyNew Providence$148K
- Timothy HendersonWayne$140K
- Anthony CostaEatontown$95K
- Gregory RoehrigManasquan$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.